Does it excite you to provide scientific and operational leadership in biostatistics, and do you have experience leading a biostatistics function across development programs? If this sounds like you, and you are ready to take on a broad area of responsibilities, then you could be our new colleague.
Your new position
As Head of Biostatistics, you will define and execute the biostatistics strategy, ensure alignment with global regulatory requirements, establish and maintain standards and provide guidance to trial design and methodology for clinical trials. This is a people leadership role with focus on leading, building and developing a team of skilled Biostatisticians contributing to key portfolio priorities.
You Will Have a Broad And Impactful Role, Including
- Provide day-to-day leadership for Biostatisticians
- Lead, coach, and develop the Biostatistics function, including capability building
- Shape and drive biostatistics strategy across the development value chain
- Guide clinical development plans and evidence generation to support decision-making
- Oversee resource planning, outsourcing strategies, and vendor oversight
- Guide on briefing documents, responses to health authority questions and regulatory submissions
- Act as a close partner to cross-functional Head of Department stakeholders (e.g., Medical & Science, Clinical Operations, Regulatory, Safety, Data Management and Statistical Programming)
Your profile
The ideal candidate is an inclusive people leader with a proactive and collaborative mindset, sound scientific judgement, and the ability to lead through influence and clarity. The role requires comfort operating in a complex, cross-functional environment and the ability to translate biostatistics insight into clear direction for teams and projects.
- Master’s degree or PhD in statistics or mathematics
- Demonstrated people leadership experience in a matrix, cross-functional environment
- Extensive biostatistics experience, e.g. as project statistician, within the biotech and/or pharmaceutical industry
- Experience supporting regulatory submissions and interactions
- Proficiency with statistical methodologies, tools and standards used in clinical development
- Excellent communication and stakeholder management skills
- Ability to influence at senior leadership level
- High standards for quality, integrity, and compliance
Your new team
You will head the Biostatistics department within Biometrics, leading a team of highly skilled and dedicated Biostatisticians. Biometrics consists of three departments (Data Management, Statistical Programming and Biostatistics) and you will be part of the Biometrics leadership team. Biostatistics plays a central role in shaping the clinical development strategy for Zealand’s compounds, ensuring scientific rigor across development programs and to interactions with regulatory authorities.
Let’s bond and be bold
We have a unique culture, characterized by excellent teamwork and strong engagement across the organization. And we want you to help us strengthen this culture.
Making bonds is at the core of everything we do. From discovering and developing the best new peptide drugs for patients, to engaging with our partners or connecting with each other. We bond through curiosity and playfulness as a team, allowing ourselves to challenge common thinking and drive future innovation. Join us and let’s bond and be bold
Interested in bonding with us? Then please apply no later than the 7th of June, 2026 or as soon as possible. The applications will be reviewed as they come in. While a cover letter is not required, please include a few sentences in your CV explaining your motivation for applying.
For further information, please contact VP, Head of Biometrics, Per Sørensen on PSorensen@zealandpharma.com.
We are committed to an inclusive recruitment process and welcome applications from all job applicants.
About Zealand Pharma A/S
Zealand Pharma A/S (Nasdaq: ZEAL) is a biotechnology company focused on the discovery and development of peptide-based medicines. More than 10 drug candidates invented by Zealand Pharma have advanced into clinical development, of which two have reached the market and three candidates are in late-stage development. The company has development partnerships with a number of pharma companies as well as commercial partnerships for its marketed products. Zealand Pharma was founded in 1998 and is headquartered in Copenhagen, Denmark, with a team in the U.S. For more information about Zealand Pharma’s business and activities, please visit www.zealandpharma.com.
